NIH Supports Buck Institute's Innovative Alzheimer's Research with "Eureka" Grant
Wednesday, July 8, 2009 - 14:56
in Health & Medicine
The Buck Institute for Age Research has received a $1.6 million dollar "Eureka" grant from the National Institutes of Health to further its innovative research in Alzheimer's disease. The highly competitive grant was awarded to Buck faculty member and founding CEO Dale Bredesen, MD. Research in the Bredesen lab focuses on Alzheimer's as a potential "prionic" brain signaling disorder that impacts brain plasticity, rather than the current dogma that Alzheimer's is a disease of toxicity stemming from damage caused by sticky amyloid plaques that collect in the brain.